Regulus Therapeutics said that it has named Garry Menzel as executive vice president of corporate development and finance.
Menzel previously served as managing director for Credit Suisse. Before that, he was a managing director of Goldman Sachs’ healthcare group. He holds a PhD in molecular biology from the University of Cambridge and an MBA from the Stanford Graduate School of Business.